The Argus II (US/Europe) and Alpha IMS (Europe) retinal implants have been approved for clinical use, and with over 100 implantees we report early benefits compared to blindness, but many hurdles yet to be overcome.

© 2015 Optical Society of America

PDF Article


You do not have subscription access to this journal. Citation lists with outbound citation links are available to subscribers only. You may subscribe either as an OSA member, or as an authorized user of your institution.

Contact your librarian or system administrator
Login to access OSA Member Subscription